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Abstract
Objectives. Effects of Zika virus (ZIKV) infection on placental
development during pregnancy are unclear. Methods. Full-term
placentas from three women, each infected with ZIKV during
specific pregnancy trimesters, were harvested for anatomic,
immunologic and transcriptomic analysis. Results. In this study,
each woman exhibited a unique immune response with raised IL-
1RA, IP-10, EGF and RANTES expression and neutrophil numbers
during the acute infection phase. Although ZIKV NS3 antigens co-
localised to placental Hofbauer cells, the placentas showed no
anatomic defects. Transcriptomic analysis of samples from the
placentas revealed that infection during trimester 1 caused a
disparate cellular response centred on differential eIF2 signalling,
mitochondrial dysfunction and oxidative phosphorylation. Despite
these, the babies were delivered without any congenital
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anomalies. Conclusion. These findings should translate to improve
clinical prenatal screening procedures for virus-infected pregnant
patients.
Keywords: histology, infection, placenta, RNA-seq, transcriptomics,
Zika virus
INTRODUCTION
Zika virus (ZIKV) caused numerous outbreaks of
infection worldwide,1 and the scale of these
outbreaks highlighted several features of ZIKV
infection that had previously been unrecognised
or under-reported. One such feature included
congenital foetal growth-associated anomalies as
a result of ZIKV infection during pregnancy,
termed congenital Zika syndrome (CZS).2,3
Pregnancy is divided into three trimesters, based
on the series of developmental changes that occur
in the foetus and the physiological changes that
occur in the mother. Understanding the nature of
the ZIKV–host interactions at each trimester is
required to determine the consequences of
maternal–foetal ZIKV transmission. Important
physiological changes occur in women during
pregnancy, including immune responses.4 While
the unique immunologic state experienced during
pregnancy prevents the mother from rejecting the
foetus,5 the state of pregnancy could increase the
mother’s susceptibility to infection.6
The placenta develops from trophectoderm
surrounding the blastocyst and rapidly grows
after implantation to establish the foetal life
support system before the rapid growth of
the foetus in the second half of pregnancy. The
placenta is the physical barrier between the
mother and her foetus. It is the site of transport
of oxygen nutrients, antibodies and waste
products between mother and baby.7 Importantly,
the placenta also protects the foetus from
infections, exhibiting a robust innate and
adaptive immune response to pathogens.8
Hofbauer cells are macrophages located within
the stroma of the placenta and can be isolated
from the placenta and be infected by ZIKV
experimentally.9 Positive ZIKV infection has been
detected in placental tissue10 and foetuses3 of
women who have terminated their pregnancies,
suggesting the virus can evade placental immune
defence mechanisms. As the risk of congenital
anomalies, including microcephaly, is largely
associated with ZIKV infection during the first
trimester of pregnancy,11 it is also possible that
ZIKV infection perturbs placental development.
Such perturbations could also upset the placental
immune function. The mechanisms underlying
how ZIKV infection in the three trimesters affects
the placental cellular responses, especially in
pregnancies without any congenital
complications, are currently unknown.
Understanding these provides an alternate
perspective regarding ZIKV pathogenesis in
asymptomatic pregnant patients.
Here, the placental cellular responses in ZIKV-
infected pregnant women were probed and the
study delineated how ZIKV infection affected
placental development in each trimester. Three
pregnant women were recruited to the study who
had been infected with ZIKV during the first,
second or third trimesters. After successful, full-
term delivery of healthy infants, the placentas
were harvested and separated into the placental
discs (chorionic villi) and foetal membranes
(chorion and amnion) to investigate the cellular
responses in these anatomically distinct structures.
Histology and immunofluorescence analyses were
used to identify any tissue parenchymal
abnormalities and immune-cell changes were
determined by immunophenotyping. This was
combined with RNA sequencing (RNA-seq) to
determine the transcriptomic profiles of these
samples. Although the number of ZIKV-infected
pregnant women recruited was low and may not
represent the entire population, it still provides
insightful data on the possible placental responses
during trimester-specific ZIKV infection.
RESULTS
Pregnant women in different trimesters
exhibited differential susceptibility to ZIKV
infection
Three ZIKV-positive pregnant women were
recruited to the study, who had been infected
with ZIKV in different trimesters (Table 1)
following the ZIKV outbreak that happened in
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Singapore in 2016.12 These patients suffered from
mild symptoms such as fever, rash and headache.
Only one patient experienced pain in her eyes.
Blood samples were taken during the acute
[5–6 days post-illness onset (PIO)] and convalescent
(9–14 days PIO) phases of infection, and analysed
for the presence of ZIKV NS3 antigens.
CD14+ monocytes are the predominant cellular
target of ZIKV.13 Interestingly, each patient
showed a different ZIKV NS3 antigen profile in
CD14+ monocytes. Firstly, 15% of Patient 1’s
CD14+ monocytes were positive for ZIKV NS3
antigens, which persisted to a lesser degree in the
convalescent phase (7.61%). Secondly, in Patient
2, ZIKV NS3 antigens were barely detectable in
CD14+ monocytes at both time points
(0.19–0.44%). Lastly, Patient 3 exhibited a
‘delayed’ infectious response, in which 2.66% of
CD14+ monocytes were positive for ZIKV NS3
antigen levels during the acute phase, which
increased to 10.1% of total CD14+ monocytes
during the convalescent phase (Table 1 and
Supplementary figure 1a, b). The different
infection profiles exhibited by the three patients
were corroborated by variations observed in their
blood immune-cell numbers (Table 1 and
Supplementary figure 2a, b) and ZIKV-specific
antibody titres (Table 1 and Supplementary figure
1c, d). Interestingly, ZIKV-specific antibody
production was weak in Patient 1, perhaps
indicating a direct consequence of ZIKV infection
on the host humoral immune response during the
first trimester. Titres of ZIKV-specific antibodies
(both IgM and IgG) did not change during the
convalescent phase in both Patients 2 and 3
(Table 1 and Supplementary figure 1c, d).
ZIKV antigen localised to placental
Hofbauer cells and persisted until birth
All three patients successfully carried infants to
term with no microcephaly or CZS, and infants
were delivered via normal vaginal deliveries with
no intrapartum complications. Once delivered, the
full-term placenta was separated into placental
discs and foetal membranes, and a series of
histologic analyses were performed. By
haematoxylin and eosin (H&E) staining of the
placental discs, villous maturity within the normal
limits of a term placenta was observed in all three
cases. The chorionic villi of all three placental discs
showed patchy dilatation featuring stromal
oedema and prominent aggregates of vacuolated
cells. These vacuolated stromal cells have the
morphologic features of villous stromal
macrophages, that is Hofbauer cells. No features
of ongoing or remote acute or chronic villitis,
intervillositis, villous necrosis or fibrosis were
observed (Figure 1a). This indicated that ZIKV
infection did not induce any overt adverse
placenta pathology. The foetal membranes of all
three placentas also showed several reactive
changes, including increased numbers of
vacuolated mononuclear cells within the
subamniotic connective tissue, in keeping with
increased infiltration of macrophages. In addition,
the amniotic epithelial cells exhibited columnar
cell metaplasia, being more pronounced in
placentas infected in the first and second
trimesters. There are no signs of acute
chorioamnionitis (Figure 1b).
Immunofluorescence staining of the placental
discs confirmed the presence of CD163+ Hofbauer
cells, which exhibit functions similar to those of
M2-like macrophages.14 Counter-staining with a
ZIKV NS3-specific antibody13 indicated that ZIKV
protein co-localised to Hofbauer cells (Figure 1c),
in line with previous reports.9 Staining of
placental discs with secondary antibody alone did
not result in any signals (Supplementary figure 3).
Thus, this ruled out autofluorescence and
indicated positive infection of the placenta,
regardless of the pregnancy trimester in which
ZIKV infection occurred. Notably, these data
showed that ZIKV proteins were present in the
placenta up to delivery, without causing any
physical harm to the newborn infant. However, it
is important to continue monitoring the newborn
as anomalies may manifest at a later time.15
The ZIKV immune response correlated with
the level of ZIKV infection in CD14+
monocytes
The immunologic response to ZIKV infection in
the three pregnant women was compared
between the acute and convalescent time points,
which will provide important insights on how the
host response is affected by the infection in
different trimesters. Blood plasma was assayed for
42 different immune mediators, including pro-
inflammatory and anti-inflammatory cytokines,
chemokines and growth factors. Plasma samples
from healthy, non-pregnant females were used as
controls. To segregate the patients based on the
immunologic response, the derived data were
ª 2019 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of
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processed by multiple factor analysis (MFA),16
which collectively analysed different
measurements made from the same set of
individuals. Both data sets were specified as two
different groups of measurements to the
algorithm.
The unsupervised data analysis clearly
segregated the samples according to healthy
controls and ZIKV-infected patients and to
convalescent and acute phases of infection along
the first principal component (PC1) of the data.
PC1 accounted for 42.5% of the variation in the
measurements across the samples (Figure 2a). The
second and third principal components (PC2 and
PC3) together accounted for 39.7% of the
variation between measurements and highlighted
the differences between individuals. Along these
axes, the patient samples from the convalescent
phase of infection were closely grouped together
compared to those from the acute phase of
infection.
Correlation of measurements with PC1, which
separated ZIKV-infected patients and healthy
controls, showed that a subset of immune
Figure 1. Zika virus (ZIKV) NS3 antigen in CD163-positive macrophages impacts stromal changes in full-term placentas. Representative
haematoxylin and eosin (H&E)-stained sections showing the placental disc (chorionic villi) and foetal membranes of three patients infected by ZIKV
at different gestational ages. (a) Aggregates of vacuolated cells morphologically in keeping with Hofbauer cells are observed in the chorionic villi
of all three infected patients. Areas highlighted by the black boxes are magnified in the lower panel. (b) Increased stromal and mononuclear cells
are noted in the subamniotic connective tissue of the foetal membranes of the infected patients. All images were captured at 409 magnification.
(c) Immunofluorescence microscopy was used to visualise ZIKV NS3 antigen (green) and CD163 protein (red) in the full-term placentas of the
ZIKV-infected patients. The white arrows indicate co-localisation of the ZIKV antigen and CD163 protein within the villous stroma of the placental
disc. All images were captured at 409 magnification.
ª 2019 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of
Australian and New Zealand Society for Immunology Inc.
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mediators (IL-1RA, EGF, RANTES and IP-10) and
neutrophils were associated with acute ZIKV
infection (Figure 2b, c). Noteworthy, neutrophil
numbers in the peripheral blood positively
correlated with the percentage of ZIKV-infected
(ZIKV NS3+) monocytes (Figure 2d and Table 1).
ZIKV infection during the first trimester of
pregnancy triggered disparate eIF2
signalling and oxidative phosphorylation in
the placenta
Transcriptomic profiling of the placental discs and
foetal membranes of the placentas was used to
investigate the cellular host response during ZIKV
infection. Both tissues were digested to obtain a
single-cell suspension: the placental disc was
further separated into CD45+ immune and CD45
non-immune fractions, to define the drivers of
ZIKV-induced cellular changes. Tissue samples
were collected in triplicate to account for tissue
heterogeneity, except those obtained from
Patient 3, where the sample was processed as a
whole, because of technical difficulties. Placental
samples from two healthy women were included
as controls.
Over 517 million paired-end RNA-seq reads
were obtained with a median of > 15 million
paired-end reads per sample mapped to the
human transcriptome, and 29 613 genes had a
detectable expression level of > 1 transcript per
million (TPM) per sample. Principal component
analysis (PCA) of the gene expression profiles
segregated the samples by their origin
(placental disc or foetal membrane), regardless
of whether they were derived from patients or
controls (Figure 3a). Patient 1 was the only
exception, as the gene expression data all
clustered together (Figure 3a, cluster 4). This
effect was further elaborated when PCA was
performed separately for each tissue type
(Figure 3b), where samples from Patient 1
segregated from the rest.
To determine the cellular differences in the
placenta of Patient 1, the unique differential gene
expression (DGE) signature was compared to
healthy controls. A large number of DEGs were
identified between the placentas of Patient 1 and
Figure 2. Immune characterisation of Zika virus (ZIKV)-infected pregnant women. Blood samples were obtained from three pregnant women
during the acute and convalescent phases of ZIKV infection. The women were infected in different trimesters of their pregnancy: P1, trimester 1;
P2, trimester 2; and P3, trimester 3. Levels of peripheral blood immune cells and immune mediators were quantified by Luminex and
immunophenotyping, respectively. Healthy controls (n = 3) were included. (a) Principal component analysis scores of the infected and healthy
women based on a collective analysis of immunophenotyping and cytokine measurements with multiple factor analysis (MFA). (b) Correlation of
immunophenotyping and cytokine measurements with the first two principal component (PC1 and PC2) axes of the MFA. (c) Heatmaps
comparing the cytokine and immunophenotyping data for each subject. (d) Correlation between infection (% ZIKV NS3+ monocytes) and
neutrophil numbers in whole blood samples.
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those from healthy controls (placental disc CD45+,
n = 674; placental disc CD45, n = 2780; and
foetal membrane, n = 2467). Conversely, few to
no DEGs were identified between the placentas
derived from Patient 2 and healthy controls
(placental disc CD45+, n = 0; placental disc CD45,
n = 51; and foetal membrane, n = 1;
Supplementary figure 4a). Unfortunately, samples
from Patient 3 could not be analysed because of
an insufficient number of replicates.
The potential functions of the DEGs in placental
tissue from Patient 1 were analysed using gene
ontology (GO), pathway enrichment and gene set
enrichment analysis (GSEA) to provide a global
overview. In the CD45 fraction of the placental
disc from Patient 1, GO analysis identified several
DEGs as ribonucleoproteins, mitochondrial genes
and histones (Figure 4 and Supplementary table
1). Ingenuity Pathway Analysis identified the role
of eIF2 signalling, as the main canonical pathway
associated with these DEGs (Supplementary figure
4b). The eIF2 pathway regulates global protein
synthesis and translation in response to stress.
Oxidative phosphorylation was also significantly
modulated, where 90% of genes involved in this
pathway showed a reduced expression by > 2-fold
compared to healthy controls. An increased
abundance of histone transcripts during viral
infection has been previously reported17,18 and
was also observed in Patient 1 (Figure 4). The data
also suggested potential modulation of oxidative
phosphorylation and eIF2 signalling in both the
CD45+ cells of the placental disc and foetal
membrane in the placenta from Patient 1
(Figure 4, Supplementary figure 4b and
Supplementary table 2).
To determine the percentages of various immune
populations, immunophenotyping of the isolated
CD45+ cells was performed (Figure 5a and
Supplementary figure 5). Correlating these
Figure 3. Principal component analysis of gene expression in placental samples. Full-term placentas from Zika virus-infected pregnant patients
were obtained and separated into the foetal membrane, and CD45 non-immune and CD45+ immune cells of the placental disc. Placentas from
two healthy women were obtained in parallel as a control. The transcriptomes of the three cell types (placental disc CD45+, placental disc
maternal CD45 and foetal membrane cells) were assessed by RNA sequencing (RNA-seq). Principal component analysis was performed by
analysing RNA-seq data either (a) collectively from all three cell types or (b) individually as each specific cell type.
ª 2019 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of
Australian and New Zealand Society for Immunology Inc.
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immunophenotyping data with the first two
principal components of the gene expression data
(Figure 5b) corroborated that the increase in
neutrophil numbers (Figure 5c) was clearly
associated with gene expression changes observed
in the placenta from Patient 1 compared to healthy
placentas. In the foetal membrane of the placenta,
several transcripts encoded by inflammatory
response genes and pathways were increased in
abundance, including NFKB1, IL-1B, TNF, TLR2,
TLR4, CXCL8, NLRP3 and NLRP6 (Supplementary
figure 4b and Supplementary table 3). Taken
together, these data suggest that ZIKV infection
during the first trimester of pregnancy could have
led to an upregulated abundance of transcripts
targeting eIF2 signalling, oxidative
phosphorylation and neutrophil numbers. These
findings would need to be corroborated with
larger sample sizes in the future.
DISCUSSION
This study recruited three pregnant women who
were infected with ZIKV during different
trimesters of pregnancy. Despite the low number
of patients recruited (one patient per trimester),
this remains an excellent opportunity to obtain an
insight into the impact of ZIKV infection during
different trimesters on host cellular responses.
Furthermore, the infection was caused by a
phylogenetically different ZIKV strain compared
to those reported in the Americas.19 Nevertheless,
a series of histologic, immunologic and
transcriptomic analyses were used to determine
the impact of ZIKV infection on pregnancy
progression and the cellular responses of the host
towards the infection. All three babies were born
at term with no observable birth defects, and all
of the ZIKV-infected mothers were clinically well,
as with majority of ZIKV-infected patients.20
However, different degrees of infection were
apparent in the level of CD14+ monocytes
between the three patients. This difference led to
a disparate immune response exhibited by the
patients. As confirmed by MFA of immune-
phenotyping and cytokine data, the three
pregnant patients can be easily separated based
on their immune response. Importantly, by
Figure 4. Placental gene expression associated with Zika virus (ZIKV) infection. Heatmaps comparing gene expression in the different placental
specimens (placental disc CD45+, placental disc CD45 and foetal membrane cells) from ZIKV-infected women infected during the first (P1),
second (P2) or third (P3) trimesters of pregnancy. Placental samples from two healthy women (H1 and H2) were obtained in parallel as a control.
Samples from H2, P1 and P2 were processed in triplicates. The most highly differentially regulated genes and pathways in P1 included EIF2
signalling, oxidative phosphorylation, histones and ribosomal RNAs. Gene expression measurements from RNA-seq in transcript per million (TPM)
scale were used to calculate a Z-score on each row.
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comparing their cytokine profiles to those of the
healthy non-pregnant female controls, several
immune mediators such as IL-1RA, EGF, RANTES
and IP-10 were associated with the acute phase of
ZIKV infection, a finding that was also observed in
ZIKV-infected non-pregnant patients.20
Interestingly, EGF and IP-10 are typically expressed
at higher levels in women carrying a foetus with
developmental anomalies.21 The association of
neutrophils with the acute phase should also be
given more attention since most studies have
focused on the role of monocytes during ZIKV
infection thus far.22,23 Neutrophils have been
shown to infiltrate the central nervous system of
ZIKV-infected immunocompromised mice24 and
may therefore be a causative element in Zika-
induced neurologic damage.
Zika virus NS3 antigen was detected in placental
tissues of all three patients at full term,
confirming a strong tropism of the virus to the
placenta regardless of the trimester of infection.25
The ZIKV NS3 antigen was detected in Hofbauer
cells, placental macrophages,9 but not in
trophoblasts. The susceptibility of trophoblastic
cells to ZIKV infection is still uncertain, with
reports indicating either permissive or resistance
towards ZIKV infection.9,26,27 Interestingly, the
localisation of the ZIKV NS3 antigen to CD163+
Hofbauer cells did not agree with the positive
detection of ZIKV RNA load in the placental
tissue. This finding may indicate that the virus has
been cleared and the NS3 antigens are merely
phagocytosed, non-infectious viral proteins. This
observation was further supported by the lack of
any pathological insults (villitis, intervillositis,
chorioamnionitis or funisitis) to the placental
tissues in any of the three patients and the lack of
detectable viral RNA by RNA-seq, performed at
the resolution sequenced. This observation also
indicated an absence of overt inflammation,
which permitted the pregnancy to progress to
term without complications. This result was
further confirmed by the absence of Hofbauer
cell-mediated hyperplasia in the chorionic villi,
which has been previously associated with
progression of congenital ZIKV infection.27
Figure 5. Zika virus (ZIKV) infection during first trimester of pregnancy triggers disparate cellular response in placental disc CD45+ cells. (a)
Relative proportions of immune subsets in placental disc CD45+ cells in ZIKV-infected patients (n = 3) and healthy controls (n = 2). (b) Principal
component analysis (PCA) of gene expression profiles of placental disc CD45+ cells from ZIKV-infected patients and healthy controls. The PCA
was performed on 30 717 genes selected by standard deviation > 0. (c) Correlation plot of immune-cell subset frequencies in placental disc
CD45+ cells with the first two principal components (PC1 and PC2) of the gene expression profiles. (d) Enrichment plot of the gene set
GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN, which was reported by GSEA as most enriched among all immunologic
gene sets (C7 of MSigDB) in the placental disc CD45+ fraction of Patient 1 vs. healthy placenta. The profile shows the running enrichment score
(green curve) and the positions of gene set members (black vertical bars) on the rank-ordered list of differential gene expression comparing the
Patient 1 vs. healthy placental disc CD45+ fraction.
ª 2019 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of
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The transcriptomic profiling of placental cells
showed that the cellular responses in Patient 1
(infected during the first trimester) were quite
different from the other two patients and healthy
controls for all three cell types analysed: placental
disc CD45+, placental disc CD45 and foetal
membrane cells. GSEA revealed that a subset of
genes in the CD45+ cells of Patient 1 (Figure 5d)
resembled those documented in the bacterium
Anaplasma phagocytophilum-stimulated human
primary neutrophils.28 This finding is not
surprising, given that isolated CD45+ cells
comprise a high proportion of neutrophils and
thus would contribute the most to the
transcriptome. More importantly, this finding also
indicates the vast number of neutrophils present
in the placenta during pregnancy. Their
participation should not be taken lightly as this
cell type may be involved in infertility,
preeclampsia and even foetal loss. Neutrophils
also participate in implantation, angiogenesis,
spiral artery modification and parturition.29
The DEGs in the placental disc, both CD45+ and
CD45 fractions, and foetal membrane of Patient
1 were strongly associated with eIF2 signalling,
oxidative phosphorylation and mitochondrial
dysfunction. eIF2 signalling is crucial in regulating
translational initiation leading to protein
synthesis, and participates in cellular stress
responses, erythropoiesis and immune responses
to viral infection.30 Perturbed eIF2 signalling in
placental development has been associated with
intrauterine growth restriction of developing
foetuses.31 In rats, eIF2 signalling was also shown
to be heavily involved in the regulation of
placental and foetal development.32 Likewise,
oxidative phosphorylation and mitochondrial
dysfunction have been associated with a range of
gestational disorders.33 Mitochondrial dysfunction
could also indicate an impairment of the antiviral
immune response.34 It is known that some viruses
attack the host cell mitochondrial network as a
form of immune evasion.35,36
The findings described herein can be translated
into the clinical prenatal screening procedures in
ZIKV-infected or any arbovirus-infected pregnant
patients. In such circumstances, abnormalities in the
numbers of leucocytes37,38 and biomarkers
indicative of ongoing inflammation39 or oxidative
stress40 and presence of any microbial infections41
should be screened as advised by the clinic. Likewise,
RNA from the amniotic fluid or amniocytes can be
profiled to determine the transcript abundance of
molecules involved in important biological
pathways.42 Adopting these steps will potentially
improve the clinical care administered to affected
patients, by identifying potential danger signs
associated with ZIKV infection.
METHODS
Ethics approval and consent to participate
Written informed consent was obtained from all
participants in accordance with the Declaration of
Helsinki for human research. The study protocol
was approved by the SingHealth Centralized
Institutional Review Board (CIRB Ref: 2016/2219).
Blood samples were collected from healthy donors
who had provided written consent, in accordance
with the guidelines of the Health Sciences
Authority of Singapore (study approval number:
NUS IRB: 10-250).
Patients and sample collection
Three pregnant women were enrolled into the
study upon admission to the KK Women’s and
Children’s Hospital, Singapore. Patient 1 was
6-weeks pregnant, Patient 2 was 17-weeks
pregnant, and Patient 3 was 35-weeks pregnant
when they presented symptoms of ZIKV infection.
Upon admission, patients were confirmed to be
infected via qRT-PCR detection of ZIKV RNA in
their urine. Whole blood samples were collected
at two time points: 0–7 days PIO and 10–14 days
PIO, representing the acute and convalescent
phases, respectively. Whole blood was collected in
EDTA Vacutainer tubes (Becton Dickinson,
Franklin Lakes, NJ, USA) after peripheral
venipuncture. Each sample was first used for
blood count, whole blood staining and viral load
quantification and then centrifuged at 256 g for
10 min to collect plasma for storage at 80°C.
Whole blood samples were also collected from
three healthy women and pre-screened for ZIKV
viral RNA and ZIKV-specific antibodies using in-
house protocols.13 Placentas from two healthy
individuals were obtained as control. All healthy
donors were non-febrile and had no signs of
acute illness during recruitment.
Placenta processing
After successful full-term delivery, the placenta
was maintained on ice and transported to the
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Singapore Immunology Network for immediate
downstream processing within 2 h of expulsion.
The term placenta was first separated into the
foetal membrane (chorion and amnion) and
placental disc (chorionic villi) layers. A small
section of the tissue was removed and placed in
10% neutral buffered formalin (NBF; Sigma-
Aldrich, Saint Louis, MO, USA) for histology and
immunofluorescence staining. The remaining
tissues were finely diced in a digestion medium
containing collagenase type 4 (0.2 mg mL1) and
DNase (0.05 mg mL1) prepared in Roswell Park
Memorial Institute medium (GE Healthcare Life
Sciences, Pittsburgh, PA, USA) containing 10%
foetal bovine serum (Thermo Fisher Scientific,
Waltham, MA, USA). Refer to supplemental
materials for more information.
The foetal membranes were incubated in
digestion medium for 3 h in a 37°C incubator
supplemented with 5% CO2. The foetal cells were
then centrifuged (400 g, 5 min) and repeatedly
washed with PBS to remove traces of digestion
medium before red blood cell (RBC) lysis. Lysis was
done with in-house RBC lysing solution containing
155 mM NH4C1 (Sigma-Aldrich), 10 mM KHCO3
(Sigma-Aldrich) and 0.1 mM EDTA (Thermo Fisher
Scientific). Lysed cells were then enumerated and
used for downstream procedures.
The placental disc was incubated in digestion
medium for 1 h, and then, the digestion medium
was carefully overlaid on Ficoll-Paque Plus (GE
Healthcare Life Sciences) at a ratio of 2:1,
respectively. The samples were then centrifuged
at 1600 g for 20 min (with minimal acceleration
and deceleration) to isolate the ‘buffy coat’
containing leucocytes. The leucocytes were
carefully removed, and traces of RBCs were
subsequently lysed. The cells were enumerated
and used for downstream procedures.
In both cases, the digestion medium was
filtered through a 100-lM filter unit after
digestion to remove any undigested tissues. The
volume of medium used was adjusted according
to the size of the tissue being digested.
Histology and immunofluorescence
Placental tissues were first fixed in 10% NBF
(Sigma-Aldrich) at room temperature for 24 h
before being processed for routine histologic
evaluation. Briefly, isolated tissues were
embedded in paraffin wax, cut into 5-lM-thick
sections, deparaffinised and then stained with
H&E. The stained sections were viewed under an
Olympus BX53 upright microscope (Olympus Life
Science, Tokyo, Japan), and images were captured
with an Olympus DP71 digital camera using an
Olympus DP controller and DP manager software.
All images were evaluated by a certified
pathologist.
Tissue sections were stained by standard
immunofluorescence technique. In brief, antigen
retrieval was performed after deparaffinisation,
using DAKO target retrieval solution, pH9. After
washing with TBS-T, the tissues were then treated
with 10% goat serum for 30 min to block the non-
specific reaction. The tissues were then incubated
overnight with various combinations of a ZIKV in-
house antibody13 (1:100) and CD163 (Thermo
Fisher Scientific; 1:50) at 4°C. The slides were
incubated with secondary antibodies (1:500) such
as Alexa Fluor 488 goat anti-rabbit IgG (Thermo
Fisher Scientific) and Alexa Fluor 594 goat anti-
mouse IgG (Thermo Fisher Scientific) for 30 min in
the dark, and the nuclei were counter-stained with
VectashieldTM Hard Set mounting medium with
DAPI. The stained slides were examined under
Nikon Eclipse 90i fluorescence microscope (Nikon,
Tokyo, Japan), and images were captured with
microscopic camera, DS-Fi3 (Nikon), using NIS-
Elements imaging software (Nikon).
Blood count
A complete blood count (CBC) was determined
using an AcT diff haematology analyser (Beckman
Coulter, California, CA, USA), according to the
manufacturer’s instructions. Beckman Coulter 4C©
Plus Tri-Pack Cell Controls (Beckman Coulter) were
used to confirm instrument accuracy and precision.
Whole blood labelling and flow cytometry
Whole blood (100 lL) was labelled as previously
described.13 Antibodies were used to identify
CD45+ leucocytes (mouse anti-human CD45;
Biolegend, California, CA, USA), high SSC-A CD16+
neutrophils (mouse anti-human CD16; Biolegend),
CD14+ monocytes (mouse anti-human CD14; BD
Biosciences, New Jersey, NJ, USA), CD3+ T cells
(mouse anti-human CD3; BD Biosciences), CD4+ T
helper cells (mouse anti-human CD4; Thermo
Fisher Scientific), CD56+ NK cells (mouse anti-
human CD56; Miltenyi Biotec, Bergisch Gladbach,
Germany) and CD19+ B cells (mouse anti-human
CD19; Thermo Fisher Scientific). Cell fixation and
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RBC lysis was performed using 19 FACS lysing
solution (BD Biosciences), and permeabilisation
using 19 FACS permeabilisation solution 2 (BD
Biosciences) before staining with a ZIKV NS3
protein-specific rabbit polyclonal antibody.13 The
labelled cells were counter-stained with a
fluorophore-tagged secondary goat anti-rabbit
IgG (H + L) antibody (Thermo Fisher Scientific),
before acquisition on a LSR Fortessa (BD
Biosciences). Dead cells were excluded using a
Live/DeadTM Fixable Aqua Dead Cell Stain Kit
(Thermo Fisher Scientific). The frequencies of
peripheral blood immune subsets were obtained
with the following formula: Percentage of specific
immune subset (obtained from immune-
phenotyping) 9 total leucocyte number (obtained
from CBC) = cellular number of specific immune
subset.
Multiplex microbead immunoassay for
cytokine quantification
Cytokine and chemokine levels in plasma from
ZIKV-infected patients were measured
simultaneously using a multiplex microbead-based
immunoassay, ProcartaPlex Human Cytokine/
Chemokine/Growth Factor Panel 1 (Thermo Fisher
Scientific), as previously described.20 Plasma
samples and reagents were prepared, and
immunoassay procedures were performed
according to the manufacturer’s instructions.
ZIKV virion-based ELISA
The presence and titres of ZIKV-specific antibodies
in the plasma of the infected pregnant women at
both acute and convalescent phases were
determined using a ZIKV virion-based ELISA, as
previously described.13 Plasma samples were
tested at 1:200 dilutions.
RNA sequencing (RNA-seq)
RNA samples, extracted from the fractions of
isolated placental cells, were treated with DNase
using an Ambion Turbo DNA-free Kit (Thermo
Fisher Scientific) and then purified using Ampure
XP beads (Beckman Coulter). The DNase-treated
RNA (2 lg) was treated with Ribo-Zero using an
Epicentre Ribo-Zero Gold Kit (Human/Rat/Mouse;
Illumina, San Diego, CA, USA) and re-purified on
Ampure XP beads. Successful RNA depletion was
verified using a Qubit (Thermo Fisher Scientific)
and an Agilent 2100 Bioanalyzer (Agilent, Santa
Clara, CA, USA), and all depleted RNA was used as
input material for the ScriptSeq v2 RNA-Seq
Library Preparation protocol. RNA was amplified
for 14 cycles, and the libraries were purified on
Ampure XP beads. Each library was quantified
using a Qubit, and the size distribution was
assessed using an AATI Fragment Analyser
(Agilent); the final libraries were pooled in
equimolar amounts. The quantity and quality of
each pool was assessed using a Fragment Analyser
and by qPCR using an Illumina Library
Quantification Kit (KAPA Biosystems, Wilmington,
Massachusetts, USA) on a LightCycler LC480II
(Roche, Basel, Switzerland), according to the
manufacturer’s instructions. The template DNA
was denatured according to the protocol
described in the Illumina cBot User guide and
loaded at a 12 pM concentration. Sequencing was
carried out on three lanes of an Illumina HiSeq
2500 with version 4 chemistry, generating
2 9 125 bp paired-end reads.
RNA-seq data analysis
Quality assessment of the RNA sequencing reads
was performed using FASTQC (version 0.11.5;
https://www.bioinformatics.babraham.ac.uk/projec
ts/fastqc/). Cutadapt (version 1.2.1)43 was used to
remove Illumina adapter sequences with option -
O 3 so that the 30 end of any reads that matched
the adapter sequence for ≥ 3 bp was trimmed.
The reads were further trimmed using Sickle
(version 1.20; https://github.com/najoshi/sickle)
with a minimum window quality score of 20.
Reads < 10 bp after trimming were removed. The
resulting clean, paired-end reads were mapped to
human transcript sequences obtained from
Gencode (version 27)44 using Salmon (version
0.9.1).45 Transcript abundances quantified by
Salmon were summarised to gene-level counts
and normalised gene-level abundances in TPM
units using the tximport R/Bioconductor package
(version 1.2.0).46
Principal component analysis was performed on
all samples using genes with TPM > 1 in at least
one sample. The TPM values were log2-
transformed after adding a pseudocount of 1.0 to
prevent negative values and used for PCA in
FactoMiner R package (version 1.33)47 with
default scaling transformation.
Differential gene expression analysis was
performed using edgeR R/Bioconductor package
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(version 3.16.5).48 Gene-level counts for samples
relevant to the conditions being compared were
loaded into edgeR, and a negative binomial (NB)
generalised linear model extended with quasi-
likelihood (QL) methods was fitted to the count
data. As recommended for gene-level counts
summarised using tximport, the transcript
abundances and average transcript lengths of
genes were used to specify the offset term in the
edgeR model in order to correct for potential
differences in transcript usage between samples.46
Low expressed genes with < 5 counts in all
samples were removed. The trended NB dispersion
was estimated using the estimateDisp function,
and the QL dispersion was estimated using the
glmQLFit function. DGE was determined using a
QL F-test (glmQLFTest function), which provides a
conservative and rigorous type I error rate
control.48 Genes with a Benjamini–Hochberg
multiple testing corrected P-value < 0.05 were
considered differentially expressed. DEG lists were
analysed with DAVID GO analysis (version 6.8),49
Ingenuity Pathway Analysis and GSEA (version
3.0)50 to identify associated biological conditions
and pathways. The curated gene sets used for
GSEA included the hallmark (H) and immunologic
signature (C7) gene sets downloaded from Broad
Institute’s Molecular Signatures Database that
accompanies the GSEA software.
Multiple factor analysis
Data from immunophenotyping of whole blood
and cytokine quantification in plasma were
analysed together using MFA16; MFA permits
several groups of variables to be studied on the
same set of individuals. Analysis was performed
with nine individual samples, including the three
ZIKV-infected patients in the acute and
convalescent phases of infection and the three
healthy controls. The immunophenotyping and
cytokine measurements were specified as two
different groups of variables consisting of log10-
transformed cell counts per lL of whole blood
and log10-transformed cytokine levels in pg mL
1
units. The analysis was carried out using R
package FactoMineR (version 1.33)47 with the
default parameters. The data were plotted using
custom R scripts. Data from placental
immunophenotyping and RNA sequencing were
also analysed using MFA. Data acquired from
placental disc and foetal membrane fractions
were analysed separately. The individuals in this
analysis included the three ZIKV-infected patients
and two healthy controls. Cellular fractions were
expressed as a percentage of the parent gate in
FACS analysis, and RNA-seq measurements were
expressed in log2 TPM units.
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